Switzerland's Galderma lifts full-year guidance after H1 sales jump

ZURICH, July 23 (Reuters) - Swiss skincare firm Galderma on Thursday reported a 24.6% jump in sales in the first half of the year and nudged up its full-year net sales growth guidance, citing double-digit growth in international markets and the U.S.

First-half sales rose to $3.13 billion, and the company now expects net sales to grow 19-21% this year from a previous target of 17-20%.

The Zug-based company said it had registered double-digit growth in both international markets and the United States as well as in all product categories, chiefly driven by volume and complemented by favourable mix.

Galderma said its full-year guidance factors in manageable exposure to announced U.S. tariffs, along with the ability to absorb potential consumer demand deterioration in the second half, given a volatile political and macroeconomic environment.

(Writing by Dave Graham, Editing by Linda Pasquini)